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The differentiation of murine trophoblast giant cells (TGCs) is well characterised at the molecular level and, to some extent, the cellular
level. Currently, there is a rudimentary understanding about factors regulating the cellular differentiation of secondary TGCs. Using day 8.5
p.c.-ectoplacental cone (EPC) explant in serum-free culture, we have found parathyroid hormone-related protein (PTHrP) to regulate cellular
changes during TGC differentiation. PTHrP greatly stimulated the formation and organisation of actin stress fibres and actin expression in
trophoblast outgrowth. This coincided with changing cell shape into a flattened/fibroblastic morphology, suppression of E-cadherin
expression, and increased cell spreading in culture. PTHrP also increased the nuclear staining of h-catenin and, similar to activator protein-
2g (AP-2g), showed microtubule-dependent nuclear localisation in vitro. These cellular and behavioural changes correlated with changes in
the expression of RhoGTPases and in both expression and phosphorylation of Eph/Ephrin kinases. The effects of PTHrP on trophoblast
cellular differentiation were abolished after blocking its action. In conclusion, PTHrP provides an excellent example of the extrinsic factors
that, through their network of activities, plays an important role in cellular differentiation of secondary TGCs.
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In rodents, the trophoblast cell lineage is specified before
implantation. Early in the postimplantation period, four
major differentiated cell types arise from this lineage:
trophoblast giant cells (TGCs), glycogen trophoblast cells,
syncytotrophoblast, and spongiotrophoblast (Rossant and
Cross, 2001; Cross et al., 2002). Secondary TGCs arise
from the ectoplacental cone (EPC), invade the uterus and
form the periphery of the extraembryonic compartment of
the placenta that directly contacts maternal decidual tissue.
Secondary TGCs control the diffusion of nutrients and
oxygen between maternal and fetal blood and produce a
variety of growth hormones. The latter induce maternal0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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pregnancy, and the proper formation and vascularisation of
the chorioallantoic placenta (Soares et al., 1998; Cross,
2000).
Differentiation of murine TGCs is fairly well understood
at the molecular and morphological levels, and is char-
acterised by exit from the cell cycle and DNA endoredu-
plication (Barlow and Sherman, 1972; Cross, 2000; Cross et
al., 2003). It also involves production of growth hormones,
e.g., placental lactogens I and II (PL-I and II, Faria et al.,
1991; Yamaguchi et al., 1992), and expression of tropho-
blast differentiation-regulating transcription factors, e.g.,
activator protein-2g (AP-2g, Cross et al., 2003).
Until recently, little was known about how TGC cell
behaviour correlated with molecular aspects of TGC
differentiation (reviewed by Sutherland, 2003). Changes in
actin cytoskeletal organisation, membrane protrusive activity
and motility occur during the transition of trophectoderm
(TE) to invasive TGCs (Sutherland et al., 1988; Parast et al.,
2001). Changes in the expression of cadherins and
connexins and adhesive behaviour are reported during this290 (2006) 13 – 31
www.e
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ger et al., 2000). The changes in trophoblast cytoskeletal
organisation correlate with changes in the activity of the
Rho family of GTPases in mouse and human (Parast et al.,
2001; Shiokawa et al., 2002). Rho activity is regulated by
Eph proteins, the largest family of receptor tyrosine kinases.
The Eph receptor family is activated by interaction with
cell-surface ligands, Ephrins, and regulates actin cytoskeletal
dynamics through RhoGTPases in several cell types
(reviewed in Murai and Pasquale, 2003; Noren and
Pasquale, 2004).
Many extracellular signals regulating murine trophoblast
differentiation remain to be clarified but recent publications
have suggested parathyroid hormone-related protein (PTHrP)
as a regulatory molecule (Nowak et al., 1999; El-Hashash et
al., 2005). PTHrP, a 139- to 173-amino acid protein, was
first isolated from tumours of patients with humoral
hypercalcaemia and is widely expressed in different cell
types (Suva et al., 1987; Wysolmerski and Stewart, 1998;
Clemens et al., 2001). In addition to functioning in a
classical autocrine or paracrine fashion, PTHrP has intracrine
actions and undergoes nuclear translocation, a process which
depends on microtubule integrity (Lam et al., 2002). PTHrP
enters the nucleus under the direction of a nuclear
localisation signal (NLS), a region of multibasic amino
acids between residues 88 and 106, to influence cell cycle
progression, proliferation and apoptosis (reviewed by Fiaschi-
Taesch and Stewart, 2003). PTHrP is a multifunctional peptide
that regulates several developmental mechanisms, including
murine parietal endoderm and primary TGC outgrowths in
vitro (Behrendsten et al., 1995; Nowak et al., 1999) and
chondrocyte proliferation and differentiation (Lanske et al.,
1996; Weir et al., 1996). It may act on TGCs in part by
mediating the effects of other local factors that induce its
expression as shown in other cell types. This includes
transforming growth factor-h (TGF-h) in primary trophoblasts
(Nowak et al., 1999) and fetal rat bone cells (Centrella et al.,
1989), and tumour necrosis factor-a (TNF-a) in human
cytotrophoblast cells (Casey et al., 1993; Yang et al., 1993).
Most recently, we have shown that PTHrP promotes
secondary TGC differentiation in vitro (El-Hashash et al.,
2005), yet little is known about the signalling pathway that
regulate TGC differentiation.
In this study, we used our established culture model
for secondary trophoblast outgrowth and differentiation
(El-Hashash and Kimber, 2004) to investigate the role of
PTHrP in TGC differentiation. PTHrP induced actin
cytoskeletal reorganisation and downregulated E-cadherin
during TGC differentiation in vitro. It also changed the
expression and phosphorylation of the cell cytoskeleton-
regulation molecules, Eph/Ephrin and the expression of
RhoGTPases. Similar to AP-2g, it showed a microtubule-
dependent nuclear translocation. Our results indicate a
role for PTHrP in stimulating trophoblast cellular differ-
entiation. PTHrP probably signals through EphB2/EphrinB
and RhoA signal molecules to induce trophoblast
differentiation.Material and methods
Experimental animals
All embryos were produced by natural mating of MF1 female mice with
stud males (Harlan Olac Ltd., UK) and husbandry was as reported (El-Hashash
and Kimber, 2004). Mating was confirmed by the presence of a vaginal plug the
following morning (day 0.5 of pregnancy).
Secondary TGC outgrowth assay
Culture of EPC explants and outgrowth assay were performed as described
before (El-Hashash and Kimber, 2004). Briefly, decidual capsules were
dissected from the uterus of day 8.5 p.c. pregnant females and placed in
DMEM medium (Invitrogen, Paisley, UK), with 10% heat inactivated fetal calf
serum. The decidual capsules were split open to isolate the embryos from
decidual tissues. EPCs were dissected from the isolated conceptus and
separated from attached TGCs with fine sterilised needles.
Isolated EPC explants were incubated for 3 days on 100 Ag/ml fibronectin
(FN)-coated coverslips in DMEM (Invitrogen) supplemented with 20 mg/ml l-
glutamine, Penicillin-Streptomycin (60 Ag/ml and 50 Ag/ml) and 2%
Nutridoma-HU (a growth factor-free growth supporting nutrient; Roche,
Mannheim, Germany) as previously reported (El-Hashash and Kimber,
2004). A giant cell was defined as one with a nucleus at least double the
diameter of standard nuclei (8–10 Am) at plating. Secondary TGCs were
identified by staining for PL-II (secondary TGC marker), and absence of
staining for vimentin, and E-cadherin (El-Hashash and Kimber, 2004). The top
right quadrant of each outgrowth was used to count the number of cells
displaying different patterns of actin organisation. Culture days were counted
from the day of attachment: days 1, 2, and 3 cultures referred to days 1, 2, and 3
post-attachment. Trophoblast cells adjacent to the EPC explant are referred to
as central EPC outgrowth, while those displaced from the explant as peripheral
trophoblast cells.
PTHrP and blocking antibody treatment
The biologically active fragment of PTHrP, PTHrP-1–34 (Bachem, St.
Helens, Merseyside, UK) was added to the medium at the start of the culture at
1 ng/ml. For PTHrP-neutralising antibody (antiPTHrP; De Miguel et al., 1998),
three concentrations: 100, 50, and 25 ng/ml were added to the cultures 24 h after
attachment. Fifty ng/ml antiPTHrP was chosen in this work as it had the
greatest inhibiting effect on PTHrP action on trophoblast cell number and area
of outgrowth. 100 ng/ml had a severe effect on explant attachment and greatly
reduced cell survival.
The antiPTHrP blocking antibody was added after 1 day of attachment
either alone at 50 ng/ml, or together with the peptide as in Nowak et al. (1999).
For the latter, PTHrP blocking antibody was diluted to 100 Ag/ml with 1.0 ng/
ml PTHrP peptide and incubated for 1 h at 37-C and 5% CO2 in air. The
antibody preparation was centrifuged at 10,000  g for 5 min to remove
immune complexes, and the supernatant added to the EPC culture. As a control,
50 ng/ml sodium azide-free rabbit IgG (Serotec, Oxford, UK) was added to
parallel cultures which gave identical results for percentage of TGCs and
expression of PL-II and AP-2c transcripts to unsupplemented medium. In this
work, unsupplemented cultures are referred to as control and PTHrP-
supplemented as treated cultures.
Treatment with cytoskeletal inhibitors
Two different cell cytoskeleton inhibitors were used, Colcemide (N-
deacetyl-N-methylcolchicine, Demecolcine, Sigma) to depolymerise micro-
tubules and Cytochalasin D (cytoD, Sigma) to inhibit actin polymerisation.
Demecolcine and cytoD were prepared as stock solutions of 10 and 1 mg/ml,
respectively, in dimethyl sulphoxide (DMSO, Sigma).
Demecolcine was added to the EPC cultures at 1.0 AM for 12–24 h at 37-C
before fixation (Dr. G. Ireland, University of Manchester, personal communi-
cation). To disassemble actin filaments, cultures were incubated with 1.0 Ag/ml
cytoD for 12–24 h at 37-C before the cells were fixed (Wodnicka et al., 1992;
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DMSO concentration.
RNA extraction
Total RNA was extracted from secondary TGCs growing in culture using
Qiagen RNAeasy total RNA mini kit (Qiagen, Crawley, UK) following the
manufacturer’s protocol. To ensure extraction of RNA from trophoblast
outgrowths but not central explants, the latter were removed using sterile fine
needles. Purity and quantity of RNA was assessed using a UV spectropho-
tometer (Pharmacia, Buckingham, UK).
RT-PCR
All primer sets were designed to span an intron (Table 1). RT-PCR was
performed as described before (El-Hashash and Kimber, 2004). Briefly, after
reverse transcription, PCR amplification was performed using the HotStarTaq
DNA polymerase kit (Qiagen), following the manufacturer’s protocol using an
Eppendorf Mastercycler gradient thermal cycler (Eppendorf, Hamburg,
Germany) under the following conditions: denaturation at 94-C for 1 min,
primer annealing at 60-C for 1 min, and primer extension at 72-C for 1 min.
PCR products were separated on 2% (w/v) agarose gel electrophoresis using a
100-bp DNA ladder for the size assessment. PCR products were normalised by
comparison with two housekeeping genes: glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) and 28S (ribosomal RNA). Amplified cDNAs were
sequenced using an automated ABI DNA sequencer (ABI Analytical, Ramsey,
NJ, USA) and results were verified by a BLAST search.
Whole mount in situ hybridisation
In situ hybridisation of mouse b-actin in EPC outgrowths was performed as
described before (El-Hashash and Kimber, 2004). Briefly, mouse cDNA for h-
actin (gift from Dr. S. Sidhu, Univ. of California, San Francisco) was purified
using a Geneclean kit (Q.Biogene, Nottingham, UK), subcloned into pGEM4Z
plasmid (Promega, Southampton, UK), and used to transform E. coli host
strain, XL-1 blue (Stratagene, California, USA) as instructed by the
manufacturers. h-actin-ligated plasmids were purified using Qiagen plasmid
miniprep purification kit (Qiagen). Digoxygenin (DIG) dUTP-labelled senseTable 1
Primer sequences used in this study
Primer Primer sequence 5VY3V (base numbe
Actin (f) CCACTCCTAAGAGGAGGATGG
(r) AGGGAGACCAAAGCCTTCAT
E-cadherin (f) AGCGGTTGAGAGCATTGACT
(r) GGATTTGAACCTGGGTCCTT
EphA2 (f) GGGGATGCCAACAGCTATAA
(r) CTCCTGCCAGTACCAGAAGC
EphrinA1 (f) CCACTGGTCTGGGCAGTATT
(r) TCCATCCCTCTGAAGTGGAG
EphB2 (f) AGGAATCACGGTCCAACAAG
(r) GTCTCCTGCGGTACTTGAGC
EphrinB1 (f) GAGAGGCCAGGGAAGAAAGT
(r) GGCAGAATGCACTTCAGGAT
RhoA (f) GTGGATGGGAAGCAGGTAGA
(r) TTGTTCCCAACCAGGATGAT
Rac1 (f) TCCTAGTTGTGGGTGTGCTG
(r) CGAAGGGATGCTCAAGAGAC
cdc42 (f) AGAAAAGTGGGTGCCTGAGA
(r) GCGGAGCACTCCACATACTT
28S (f) TAACCTGTCTCACGACGGTCT
(r) CAGGGATAACTGGCTTGTGG
GAPDH (f) TCTGAGGGCCCACTGAAG
(r) AGGGTTTCTTACTCCTTGGAGG
(Key)—(f) forward primer; (r) reverse primer, (bp) base pairs.and antisense riboprobes were generated by in vitro transcription using a DIG-
RNA labelling kit (Roche) as in Sidhu and Kimber (1999).
EPC outgrowths were fixed in 4% PFA, treated with absolute methanol:
30% hydrogen peroxide (5:1), then proteinase K (50 Ag/ml, Sigma), and refixed
in 0.2% glutaraldehyde (Sigma) /4.0% PFA. They were treated with 0.1% (v/v)
NaBH4 (Sigma) then with pre-hybridisation buffer, and incubated with the
riboprobes overnight at 50-C. Detection involved anti-DIG antibody conju-
gated to alkaline phosphatase (Roche) overnight at 4-C, followed by colour
development with nitro blue tetrazolium chloride (NBT, Sigma) and 5-bromo-
4-chloro-3-indolyl-phosphate (BCIP, Roche). Cultures were mounted in
gelvatol (Fisher Scientific, Loughborough, UK), and examined under bright
field. In situ hybridisation on paraffin section was performed as described
previously (El-Hashash and Kimber, 2004).
Immunocytochemistry of EPC outgrowths
Immunocytochemistry of EPC outgrowths was carried out according to our
standard protocol for EPC outgrowth (El-Hashash and Kimber, 2004). Briefly,
unless otherwise stated, trophoblast outgrowths were fixed in 4% paraformal-
dehyde (PFA, Sigma). For Rac1 staining, cells were fixed in 4% PFA for 10
min, followed by 2% acetic acid (BDH) in phosphate buffered saline (PBS) for
30 min and finally in ethanol: acetic acid (95:5) for 2 min at room temperature.
For staining of RhoA, cells were fixed in absolute methanol for 5 min at
20-C. Outgrowths were permeabilised in 0.01% TritonX-100. After a
blocking step, outgrowths were incubated overnight at 4-C with one of the
antibodies mentioned in Table 2. Irrelevant antibody of the same isotype acted
as a negative control. Outgrowths were washed and incubated with the relevant
secondary antibody, mounted in Vectashield containing 4,6-diamidino-2-
phenylindole (DAPI) and photographed using an Olympus Vannox epifluor-
escence microscope (Olympus Optical Ltd., Tokyo, Japan).
Staining of actin with fluorescence-labelled Phalloidin
Staining of actin filaments was carried out using Texas-Red Phalloidin
(Molecular Probes, Paisley, UK) as instructed by the manufacturer. Outgrowths
were fixed in 4% PFA, permeabilised, washed, and blocked in PBS containing
1% BSA. They were incubated for 20 min at room temperature with Texas-Red
Phalloidin diluted 1/40 in PBS containing 1% BSA. Outgrowths were then
washed and mounted in Vectashield containing DAPI. For double labelling ofr of primer) Product size (bp) Gene Bank no.
192 X03672
240 X60961
232 BC006954
243 BC002046
240 BC043088
244 BC021656
212 AF178959
223 X57277
195 U37720
180 BC010987
200 NM_008084
Table 2
Primary antibodies used in this work
Antibody Specification Dilution Antigen Source
Decma-1 Rat IgG 1:50; IF E-cadherin R&D System, Oxon, UK
AP-2g Rabbit Polyclonal 1:250; IF Activator protein-g Active Motif, Rixensart, Belgium
PTHrP Rabbit Polyclonal 1:100; IF PTHrP Oncogene Research Products
h-tubulin Mouse IgG 1:100; IF 1:500; WB h-tubulin microtubules Prof. V. Allan, Univ. of Manchester
Actin Mouse IgM 1:200; IF, 1:10000; WB Actin micro-filaments Oncogene Research Products
h-Catenin Mouse IgM 1:100; IF, 1:500; WB h-Catenin BD Biosciences, California, USA
11-5F Rabbit Polyclonal 1:200; IF Desmoplakin Prof. D. Garrod, Univ. of Manchester
EphA2 Mouse IgG 1:100; IF, 1:1000; WB EphA2 protein kinase Sigma, St Louse, USA
EphrinA1 Goat Polyclonal 1:250; IF, 1:2000; WB EphrinA1 protein kinase Sigma
EphB2 Goat Polyclonal 1:200; IF, 1:1000;WB EphB2 protein kinase Santa Cruz
EphrinB1 Goat Polyclonal 1:200; IF, 1:1500; WB EphrinB1 Sigma
RhoA Mouse IgG 1:100; IF, 1:500; WB RhoA small GTPase Santa Cruz
Rac1 Mouse IgG 1:100; IF, 1:1000; WB Rac1 small GTPase Upstate Biotech, Buckingham, UK
cdc42 Mouse Polyclonal 1:100; IF, 1:500; WB cdc42 small GTPase BD Biosciences
4G10 Mouse IgG 1:1000; WB Antiphospho-tyrosine Upstate Biotechnology
Key: IF, immunofluorescene; WB, Western blotting.
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then washed and stained with PTHrP antibody (1:100, Oncogene Research
Products, rabbit IgG) as described in the immunocytochemistry of outgrowths
above. Negative control incubations were with irrelevant antibodies of the same
isotype. Actin staining was performed in triplicate. A minimum of three EPC
outgrowths, grown on different occasions, were used in each replicate.
Double-labelling for microtubules
For double staining of microtubules (h-tubulin antibody) with either PTHrP
or AP-2g antigens, outgrowths were fixed in absolute methanol for 10 min at
20-C, followed by 4% PFA for 15 min at room temperature. Outgrowths were
permeabilised and blocked in 0.1% bovine serum albumin (BSA) and 0.3%
Triton X-100 for 1 h. They were incubated overnight at 4-C with a mixture of
anti-h-tubulin antibody (1:100, Prof. V. Allan, University of Manchester,
mouse IgG, Allan and Kreis, 1986) and either PTHrP or AP-2g antibody (Table
2) premixed at the appropriate dilution. Outgrowths were then washed and
incubated in appropriate FITC-conjugated secondary antibody for either PTHrP
or AP-2g for 1 h. After washing outgrowths were incubated with an appropriate
TRITC/Rodamine-conjugated secondary antibody for h-tubulin for 1 h,
washed, and mounted in Vectashield containing DAPI.
To test the specificity of secondary antibodies, control immunocytochem-
ical reactions were carried out by replacing the secondary antibody of h-tubulin
with that for PTHrP/AP-2g and vice versa. Negative controls were carried out
by substituting each primary antibody with an appropriate irrelevant antibody.
Specificity controls included PTHrP peptide pre-incubated with its neutralising
antibody. A minimum of three EPC outgrowths grown on different occasions
were used in each of 3 replicates.
Confocal microscopy
A multi-photon scanning laser confocal microscope (Bio-Rad, Herts, UK)
was used to visualise trophoblast outgrowths. A Z-series of 2.5 Am optical
sections was collected. They were then analysed and reconstructed using
confocal assistant software (Bio-Rad, version 4.02).
Western blotting
After removal of the central EPC explant, trophoblast cells were washed in
PBS, rapidly lysed using ice-cold protein lysis buffer (50 mM Tris–HCl (pH
8.0), 150 mM NaCl, 0.02% sodium azide, 1% NP-40, Sigma, and 1/100 diluted
protease inhibitor cocktail, Calbiochem, Darmstadt, Germany) for 20 min at
room temperature, and scraped from the dish. Cell lysates was centrifuged and
supernatants were removed. The protein concentration was determined by the
bicinchoninic acid (BCA) assay (Pierce, Rockford, UK), using BSA (Sigma) as
standard.Protein samples (25 Ag/ml) from whole-cell lysates were denatured and
separated on SDS-PAGE gels (Bio-Rad) at 125 V for 75 min. Twenty-five Ag of
protein was loaded/well. Protein was electro-transferred onto polyvinylidene
difluoride (PVDF) membranes (Amersham Biosciences, Buckingham, UK)
using a Mini Trans-Blot transfer cell (Bio-Rad). Membranes were blocked with
5% (w/v) dried skimmed milk (Premier International Foods, Lancs, UK), and
0.1% (v/v) Tween-20 in PBS (PBS-T, pH 7.5). They were then incubated
overnight at 4-C with one of the antibodies mentioned in (Table 2) at a
concentration predetermined by a dot/blot assay, or an irrelevant antibody. An
appropriate horseradish peroxidase-conjugated antibody (Sigma) was used as
secondary antibody. Protein bands were detected by an enhanced chemilumi-
nescence (ECL) kit (Amersham) as recommended by the manufacturer.
Twenty-five Ag protein/well was loaded and blotted, and anti-h-tubulin
antibody (Table 2) was used to control for equal loading. Western blotting
was performed in duplicate on protein samples from cultured trophoblast cells
grown on different occasions.
Immunoprecipitation/phosphorylation assessment
Trophoblast cells were stimulated by adding PTHrP to the culture for 1
h before harvesting. Harvested cells were lysed and taken through the BCA
protein determination assay as above. Protein-G-agarose conjugated beads
(Sigma) were washed and hydrated in 20 mM PBS, pH 7.0. A 250-Al protein
sample was precleared of non-specific binding to the protein-G-agarose
conjugated beads by incubation with 50 Al of beads overnight at 4-C. The
sample was then centrifuged to pellet the beads and the supernatant was
transferred into a fresh tube. The precleared sample was incubated with EphB2
antibody (1 Ag/ml) for 2 h at 4-C. A 50-Al aliquot of fresh protein-G-agarose
conjugated beads were added to the sample, incubated for 2 h at 4-C, collected
by pulsing, and washed in PBS. The agarose beads were resuspended in loading
buffer and protein was processed with SDS-PAGE and electrophoretically
transferred to the PVDF membrane as described in Western blotting above,
using antiphosphotyrosine antibody, 4G10 (1:1000 mouse IgG, Upstate).
Twenty-five Ag protein/well was loaded and blotted using anti-h-tubulin
antibody to control for equal loading.
To confirm protein identity, the PVDF membrane stored at 4-C was
stripped and reprobed with the same primary antibody used for immunopre-
cipitation following membrane manufacturer’s (Amersham) protocol. Immu-
noprecipitation and Western blotting were performed in duplicate on different
protein samples. Protein samples were immunoprecipitated from lysed
trophoblast outgrowths (15 outgrowths/sample) grown on different occasions.
Statistical analysis
Data were tested for normality and were analysed using ANOVA on SPSS
computer software (SPSS Inc, Illinois, USA).
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PTHrP changes trophoblast cell morphology and spreading
in vitro
We and others previously reported that secondary tropho-
blast cells grown in a serum-free medium show a variety of cell
morphologies (Romagnano and Babiarz, 1990; El-Hashash and
Kimber, 2004). Early outgrowths appeared as a cohesive
monolayer sheet of cells, with a close cell–cell contact and
epithelial appearance at 24 h post-attachment. At 30–48 h, two
cell morphologies were seen in the EPC culture: small clusters
of rounded trophoblast cells and some fibroblastic cells with
characteristic giant nuclei (Fig. 1A).
After treatment with PTHrP, EPC outgrowths rapidly
formed a monolayer sheet of cells during 24 h of attachment
(data not shown). These outgrowths had large numbers of
elongated trophoblast cells, which were dispersed in a less
aggregated formation with minimum cell–cell contact and
giant nuclei even close to the EPC explant (Fig. 1B). In
cultures treated with PTHrP-neutralising antibody, the majority,
if not all, trophoblast cells were rounded and few were discrete.
Most cells had aggregated together to form colonies (Fig. 1D),
a characteristic morphology and behaviour of undifferentiated
trophoblast stem (TS) cells (Yan et al., 2001).
PTHrP stimulates actin cytoskeleton formation and
organisation and actin expression during TGC
differentiation in vitro
Organisation of the actin cytoskeleton into stress fibres has
been considered as a specific, early characteristic of TGCFig. 1. Phase contrast microscopy images showing the appearance of EPC tropho
antiPTHrP antibody. (D) antiPTHrP antibody only. Note the flattened, fibroblastic
panel B, discrete, rounded cells (black arrowheads and inserted box) and cell
ectoplacental cone. Scale bar: 30 Am.differentiation (Parast et al., 2001). Since PTHrP induces
secondary trophoblast cell morphology, we examined whether
it stimulates cytoskeletal changes during TGC differentiation in
vitro. Secondary trophoblast cells grown close to the EPC have
been considered to be proliferative cells, while peripheral cells
are differentiated TGCs (Guillemot et al., 1994; Cross, 2000).
In control cultures, trophoblast cells were slightly spreading
with a few central actin stress fibres (Figs. 2A, C). On day 1 of
control culture, peripheral bands of actin were abundant in cells
growing close to the explant (Fig. 2A), as in slightly flattened
peripheral trophoblast cells on day 2 (Figs. 2C, 4A). On day 2,
cytoplasmic dots of actin were seen in trophoblast cells (Fig.
4A), which moved away from the explant and became more
flattened. These cells grew in size and had greater numbers of
actin stress fibre bundles by day 3 (Fig. 2E). This suggests that
actin assembly and reorganisation increases with the differen-
tiation of peripheral TGCs. In PTHrP-treated cultures, both
cells close to the explant (Fig. 2B) and peripheral trophoblast
cells (Figs. 2D, F) grew in size and became more flattened.
They also showed a marked increase in the formation and
rearrangement of actin stress fibres in both central and
peripheral cell regions (Figs. 2B, D, F), comparable to control
cells (Figs. 2A, C, E). The increase in actin protein expression
observed with Phalloidin staining was confirmed with anti-
actin antibody (Figs. 2G, H).
Similarly, expression of actin transcripts increased in PTHrP-
treated trophoblasts in vitro (Figs. 3A, D, F), and was
downregulated after blocking PTHrP action (Fig. 3B). Interest-
ingly, actin mRNA was highly expressed by TGCs in vivo,
distinguishing them from surrounding uterine cells (Fig. 3H). No
non-specific signals were shown in control hybridisation with
sense probes (Fig. 3G). These results indicate that PTHrPblast cells after 2 days of attachment. (A) control (B) PTHrP (C) PTHrP and
morphology of cells (inserted box) and the increase of cell size (arrows) in
clusters (white arrowhead) in the aggregated population in panel D. EPC,
Fig. 2. Influence of PTHrP treatment on actin cytoskeleton organisation and expression in secondary trophoblast cells stained with Texas Red Phalloidin (A–F), or
anti-actin antibody (G, H). Note intense central and peripheral stress fibres on all days of culture in cells near the explant (arrows) (B), and peripheral cells (D, F)
treated with PTHrP. Note also abundant peripheral bands of actin on day 1 (A) and day 2 (C) (arrowheads) in cells growing in control cultures. Also note the increase
of trophoblast cell size in PTHrP-treated culture (D, F). EPC, ectoplacental cone. Scale bar: 10 Am.
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already presents G-actin protein.
The increase in stress fibre formation and organisation by
PTHrP was drastically inhibited after neutralising PTHrP action
(Fig. 4). Only weak peripheral bands of actin and a few stress
fibres were observed in EPC cultures treated with PTHrP-
blocking antibody in combination with PTHrP (Fig. 4C). In thepresence of PTHrP-blocking antibody alone, the intensity of F-
actin labelling was further diminished and actin fibres were
restricted to the cell cortex (Fig. 4D). The central stress fibres
were greatly disrupted and hardly detected, while peripheral
actin fibres were reduced in their width but still seen at the cell
cortex after blocking PTHrP (Fig. 4D). A fundamental change in
trophoblast cell morphology accompanied the cytoskeletal
Fig. 3. (A) Expression of actin and E-cadherin transcripts by trophoblast cells in control or PTHrP-treated cultures. (B) Expression of actin and E-cadherin
transcripts by day 2 trophoblast cells treated with PTHrP, PTHrP and antiPTHrP antibody, or antiPTHrP antibody only. Note increased E-cadherin expression after
blocking PTHrP action. Reactions were normalised to GAPDH and 28S housekeeping genes. For each gene, PCR was performed in triplicate on different cDNA
samples at cycle number 15 for actin, 28 for E-cadherin, and 20 for GAPDH and 28S. cont., control; ve (no RT). The predicted sequence sizes were 192 bp for
actin, and 240 bp for E-cadherin. (C–G) In situ hybridisation for actin on day 2 EPC trophoblast cells (C–F), or to a section of day 8.5 mouse embryo; positive
control (H). (E, F) represent higher magnification of cells marked with asterisks in panels C, D respectively. Note hybridisation is to the cytoplasm (arrows) in cells
grown in control cultures (E) and in vivo trophoblast cells (H), or to both cytoplasm and nucleus (circled) in PTHrP-treated cells (F). (G) Hybridisation of trophoblast
cells with sense probes for actin. The EPC is immediately below the image in panels G and H. EPC, ectoplacental cone. N, nucleus. 2-TGC, secondary trophoblast
giant cells. Scale Bar: 10 Am.
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aggregated close to the explant (Figs. 1D, 4D), compared to
PTHrP-treated cells (Figs. 1B, 4B).
To quantitate the change in stress fibre formation by PTHrP,
the percentage of cells with stress fibres or other patterns of actin
assembly was assessed (Fig. 4E). Forty percent of cells had
peripheral patches and central dots of actin in control cultures.This was twofold higher than in PTHrP-treated cells (18%). In
PTHrP-treated cultures almost three quarters (73%) of the
examined cells contained prominent stress fibres, as compared
to only 48% of those grown in control cultures. This percentage
was significantly reduced to 2% in cultures treated with PTHrP-
neutralising antibody alone, which had 81% of cells with sparse
stress fibres restricted to the cell cortex. Together, these data
Fig. 4. The effect of neutralising PTHrP action on the organisation of actin cytoskeleton and cell morphology of day 2 trophoblast cells. Note circularly distributed
peripheral bands of actin (arrows), intense actin dots (double arrowheads), and few stress fibres in control cells (A), and in cells treated with PTHrP and antiPTHrP
antibody (C). Note also well organised and intense central and peripheral stress fibres in parallel with fibroblastic cell morphology in PTHrP-treated cells (B), and
sparse fibres in cell cortex (arrowheads) in parallel with epithelial-like morphology in cells treated with antiPTHrP antibody alone (D). EPC, ectoplacental cone.
Scale bar: 10 Am. (E) histogram shows the percentage of trophoblast cells displaying different patterns of actin organisation in day 2 EPC cultures after different
treatments. Results are given as mean T SEM of three sets of experiments. Number of explants, n = 12. Bars carrying the same letters (a, b, c, d) are significantly
different from the control ( P < 0.05; ANOVA–Dunnett test). Number of cells analysed = 1200 (PTHrP-treated; control cultures), 1163 (cultures treated with PTHrP
and antiPTHrP antibody), and 1186 (antiPTHrP antibody-treated cultures).
A.H.K. El-Hashash, S.J. Kimber / Developmental Biology 290 (2006) 13–3120indicate that PTHrP stimulates the formation and reorganisation
of actin cytoskeleton, changes cell morphology and probably
reduces cell–cell contact, which are characteristics of differen-
tiated TGCs.
PTHrP effect on E-cadherin, Desmosomes, and b-catenin
expression by trophoblast cells
In a recent paper, we reported that PTHrP increases
secondary trophoblast cell spreading in vitro (El-Hashash et
al., 2005). To determine the effect of PTHrP on trophoblast
cell–cell adhesion, we examined changes in E-cadherin anddesmoplakin expression by PTHrP (Figs. 3, 5). Transcripts for
E-cadherin were nearly undetectable in trophoblast cells in vitro
(Fig. 3A), but upregulated after blocking PTHrP action (Fig.
3B). Similarly, E-cadherin protein staining was undetectable in
control cultures (Figs. 5A, C), but was obvious at trophoblast
cell–cell adhesion sites in the presence of PTHrP-blocking
antibody (Figs. 5B, D). This suggests an inhibitory effect of
PTHrP on E-cadherin transcript and protein expression. On the
contrary, desmoplakins 1 and 2, obligate components of
desmosomal junctions, were readily detectable at the areas of
cell–cell contact (Fig. 5E). They were not apparently changed
after addition of PTHrP (Fig. 5F).
Fig. 5. Staining of day 2 peripheral secondary trophoblast cells with anti-E-cadherin antibody (A–D), anti-desmoplakin antibody (E, F) or anti-h-catenin antibody
(G, H). (C–H) Double labelled with DAPI, with panels C, D equivalent to panels A, B respectively. Note undetected staining for E-cadherin protein in cells grown in
control cultures (A) and its presence at cell –cell contact points in cells treated with antiPTHrP (B). Inserted box in H is a higher magnification (10) of the small box
and shows high nuclear staining of h-catenin protein in PTHrP-treated cells (arrows), comparable to control cells (arrowheads) (G). Scale bar: 10 Am.
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skeleton, while unbound h-catenin protein is prone to degrada-
tion, a process which is suppressed by Wnt signalling
(Gumbiner, 2000; Daniels et al., 2001).h-catenin can translocate
to the nucleus, and in conjunction with TCF family proteins can
repress E-cadherin expression (Jamora et al., 2003) and activate
cyclin D1 and c-myc (He et al., 1998; Shtutman et al., 1999). To
determine if PTHrP affects the subcellular location of h-catenin,
its distribution was compared between PTHrP-treated and
control trophoblast cells (Figs. 5G, H). Weak immunoreactivity
for h-catenin was localised to the area of cell–cell contact inboth PTHrP-treated and control cells (Figs. 5G, H). However,
there was an increase in the intensity of h-catenin staining in the
nuclei of PTHrP-treated cells (Fig. 5H), suggesting a role for
PTHrP in the elevation of nuclear translocation of h-catenin.
PTHrP changes the expression and phosphorylation of
Eph/Ephrin tyrosine kinases
Eph receptors negatively regulate MAPK/ERK pathway and
this serves at least two roles; to reduce mitogenic signalling and
to induce cytoskeletal reorganisation of cells grown in culture
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reduces mitogenesis in days 2–3 of secondary trophoblast
cultures (El-Hashash et al., 2005), we investigated whether this
and the increase in actin organisation seen in days 2–3 PTHrP-
treated cultures was accompanied by changes in Eph/Ephrin
kinases. Transcripts for EphrinA1, EphA2, EphrinB1, and
EphB2 are expressed in placental cDNA (data not shown), and
in control trophoblast cells (Fig. 6A). RT-PCR bands for
EphrinA1, EphrinB1 and EphB2 mRNA expression were
brighter in PTHrP-treated, compared to control cells at all
culture days (Fig. 6A). Little change in EphA2 transcripts was
observed after addition of PTHrP (Fig. 6A). Very weak
fluorescence for EphrinA1, EphA2, EphrinB1 and EphB2
was observed in day 1 PTHrP-treated and control cells (data
not shown). Day 3 peripheral trophoblast cells showed intense
staining for EphrinA1 and some for EphA2 (Figs. 6C, F). This
did not change after addition of PTHrP (Figs. 6D, G). No
staining was evident using irrelevant primary (Figs. 6E, H).Fig. 6. (A) Expression of EphrinA1, EphA2, EphrinB1, and EphB2 transcripts in da
cDNAwere compared with GAPDH and 28S housekeeping genes. For each gene, P
25 for Ephrin A1, EphA2, EphrinB1, EphB2 and 20 for GAPDH and 28S. ve, nega
EphA2, 244 bp for EphrinB1, 240 bp for EphB2, 200 bp for GAPDH, and 180 bp for
treated cultures with antibody for EphrinA1 or EphA2. Extracted protein samples w
same amount of protein was loaded and equal loading was confirmed by blotting p
incubated with irrelevant antibodies. Molecular weight indicated at 24 kDa for Eph
weight markers are indicated. (C, D, F, G) Expression of EphrinA1 (C, D) and Eph
treated (D, G) cultures. Negative control immunostaining for EphrinA1 (E) or EphProtein bands with expected molecular masses of 24 and 140
kDa for EphrinA1 and EphA2, respectively were detected in
the cell lysates (Fig. 6B). Addition of PTHrP to the culture had
no effect on band intensity for EphrinA1 and EphA2 kinases
(Fig. 6B).
Similarly, there was intense intracellular fluorescence for
EphrinB1 (Figs. 7C, D) and EphB2 (Figs. 7F, G) in control and
PTHrP-treated peripheral trophoblasts, with no evidence of
non-specific staining (Figs. 7E, H). However, staining intensity
was slightly greater and increased signal localised to the cell
membrane in PTHrP-treated cells stained with EphrinB1 or
EphB2 antibody (Figs. 7D, G). By contrast, EphB3 protein
kinase was undetectable in control and PTHrP-treated cells
(data not shown). Antibodies for EphrinB1 and EphB2
recognised apparent 60 kDa and 116 kDa band, respectively,
as expected in cell lysates (Fig. 7A). The EphB2, but not
EphrinB1, protein was slightly upregulated as indicated by a
more intense band after treatment with PTHrP (Fig. 7A).y 3 trophoblast cells in either PTHrP-treated or control cultures. Changes in the
CR was performed in triplicate on different cDNA samples and at cycle number
tive control (no RT). The predicted sizes were 243 bp for EphrinA1, 232 bp for
28S. (B) Western blots of day 3 secondary trophoblast cells in control or PTHrP
ere run on either 6% (for EphA2), or 15% (for EphrinA1) SDS-PAGE gel. The
rotein samples with an anti-h-tubulin antibody. (ve) negative control samples
rinA1, 140 kDa for EphA2 and 50 kDa for h-tubulin. Positions of molecular
A2 (F, G) proteins in day 3 peripheral trophoblast in control (C, F) or PTHrP-
A2 (H) double labelled with DAPI. Scale bars: 10 Am.
Fig. 7. (A) Western blots of day 3 trophoblast cells grown in control or PTHrP treated cultures with antibody for EphrinB1 or EphB2. Extracted protein samples were
run on either 6% (for EphB2) or 10% (for EphrinB1) SDS-PAGE gel. (B) Antiphosphotyrosine immunoblotting of EphB2 of day 3 trophoblast cells after induction
with PTHrP. Protein samples were immunoprecipitated with antibody for EphB2, run on 6% SDS-PAGE and probed with an antiphosphotyrosine (pTyr) antibody
(upper panel). Blots were subsequently stripped and reprobed with the antibody used for the immunoprecipitation (middle panel). Equal levels of protein were
applied as detected by h-tubulin housekeeping levels (bottom panel). (ve) negative control samples incubated with irrelevant antibodies. Molecular weight
indicated at 60 kDa for EphrinB1, 116 kDa for EphB2, and 50 kDa for h-tubulin. Positions of molecular weight markers are indicated. (C, D, F, G) Expression of
EphrinB1 (C, D) and EphB2 (F, G) proteins in day 3 peripheral trophoblast cells in control (C, F) or PTHrP-treated (D, G) cultures. Negative control immunostaining
for EphrinB1 (E) or EphB2 (H) double labelled with DAPI. Scale bars: 10 Am.
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EphB2 kinase, day 3 trophoblast cells were induced by adding
1.0 ng/ml PTHrP to the culture medium for 1 h before harvest-
ing. Harvested cells were lysed, immunoprecipitated and
immunoblotted. Western blotting of anti-EphB2 precipitated
proteins with antiphosphotyrosine antibody showed that PTHrP
stimulates tyrosine phosphorylation of EphB2 to give a 116 kDa
band, as expected (Fig. 7B). In the untreated trophoblast cells,
this band was weaker than that of PTHrP-treated cells.
PTHrP promotes changes in RhoGTPase expression
Eph kinases have been shown to regulate actin dynamics
through small GTPases of the Rho family (Rho, Rac, and
cdc42; Shamah et al., 2001; Irie and Yamaguchi, 2002; Penzes
et al., 2003). We therefore examined the expression of RhoA,
cdc42 and Rac1 to explore whether induction of EphB2 by
PTHrP was accompanied by changes in RhoGTPases (Figs. 8,
9). Transcripts for RhoA, cdc42 and Rac1 were expressed incontrol trophoblast cells (Fig. 8A). In PTHrP-treated cells,
RhoA mRNAs increased, while cdc42 transcripts drastically
decreased compared with control cells (Fig. 8A). Expression of
RhoA mRNAs was greatly reduced, while cdc42 transcripts
increased in cultures treated with PTHrP-neutralising antibody
(Fig. 8B). No apparent change in Rac1 transcripts was
observed in PTHrP-treated cells (Fig. 8A).
Similarly, intense cytoplasmic staining for RhoA and cdc42
was seen in control cultures (Figs. 8C, D). Expression of RhoA
increased (Fig. 8F), while cdc42 fluorescence staining greatly
decreased (Fig. 8G) in PTHrP-treated cells. This was confirmed
by immunoblot analysis of protein extracted from day 3
trophoblasts, which showed expected bands for cdc42 and
RhoA proteins with molecular masses of 22 kDa and 24 kDa,
respectively (Fig. 9). PTHrP treatment reduced cdc42, but
clearly increased RhoA protein levels as indicated by the
changes in their band intensity (Fig. 9). Interestingly, there was
a difference in Rac1 protein expression between trophoblast
cells near the explant and peripheral cells (Figs. 8E, H).
Fig. 8. (A) Expression of RhoA, cdc42 and Rac1 transcripts in day 3 secondary trophoblast cells grown either in control or PTHrP-treated cultures. (B) Expression of
RhoA and cdc42 mRNAs in trophoblast cells treated with PTHrP, PTHrP and antiPTHrP antibody, or antiPTHrP antibody only. Reactions were normalised to
GAPDH and 28S housekeeping genes. For each gene, PCR was performed in triplicate on different cDNA samples, and at cycle number 25 for RhoA, cdc42 and
Rac1, and 20 for GAPDH and 28S. ve, negative control (no RT). The predicted sizes were 212 bp for RhoA, 195 bp for cdc42, 223 bp for Rac1, 200 bp for
GAPDH, and 180 bp for S28. (C–H) Staining of day 3 secondary trophoblast cells growing in control (C, D, E) or PTHrP-treated (F, G, H) cultures with antibody for
RhoA (C, F), cdc42 (D, G) or Rac1 (E, H) protein. (D, G) double labelling with DAPI. EPC, ectoplacental cone. Scale bars: 10 Am.
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explant in both control (Fig. 8E) and PTHrP-treated (Fig. 8H)
cultures. However, fluorescence for Rac1 was more intense in
peripheral cells, particularly in PTHrP-treated cells on day 3
(Fig. 8H). Rac1 antibody recognised a weak 21 kDa band, as
expected, in cell lysates (Fig. 9). PTHrP did not increase the
intensity of the Rac1 protein band (Fig. 9). Unfortunately, it
was not possible to obtain sufficient protein from this primary
explant culture to examine the level of activation of RhoA or
Rac1 by pull-down or other assays currently available.
Microtubule-dependent nuclear localisation of PTHrP and
AP-2c in trophoblast cells
PTHrP shuttles between the cytoplasm and nucleus, and this
depends on microtubules, but not actin, in osteosarcoma cells
(Lam et al., 2002). PTHrP receptor, PTHR1, may also belocalised to the nucleus (Watson et al., 2000a,b). Immunostain-
ing for PTHrP revealed that it is associated with distinct
filamentous structures, besides its nuclear localisation in
secondary trophoblast cells (El-Hashash et al., 2005). To
determine which cytoskeletal elements are involved in PTHrP
nuclear translocation in trophoblast cells, we performed double
immunostaining for PTHrP and actin stress fibres or micro-
tubules (Fig. 10). No detectable association was seen between
endogenous PTHrP and actin fibres (Fig. 10A), and PTHrP
nuclear staining was not changed after disrupting actin fibres
with Cytochalasin D (data not shown). Notably, PTHrP protein
colocalised with h-tubulin-stained filamentous microtubules in
the cytoplasm (Figs. 10B–E). At high power and where the
staining was less intense, PTHrP staining was obviously
punctate along the course of microtubules (Fig. 10E). PTHrP
localisation in the nucleus was also evident (Fig. 10E). PTHrP
colocalisation with h-tubulin was clearly evident when green
Fig. 9. Western blots of day 3 EPC trophoblast cells grown in either control or
PTHrP-treated cultures with antibodies for RhoA, cdc42 or Rac1. Extracted
protein samples were run on 15% SDS-PAGE gel. (ve) negative protein
samples incubated with irrelevant antibody. Molecular weight indicated at 24
kDa for RhoA, 22 kDa for cdc42, 21 kDa for Rac1, and 50 kDa for h-tubulin.
Equal levels of protein were applied as detected by h-tubulin housekeeping
levels (bottom panel). Positions of molecular weight markers are indicated.
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reactivity between secondary antibodies for PTHrP and h-
tubulin was evident (Fig. 10H). Confirmation studies per-
formed using trophoblast cells pre-treated with the microtubule
inhibitor, Demecolcine but not the vehicle (DMSO), showed an
absence of nuclear staining for PTHrP (Figs. 10F, G). PTHrP
was localised only to the cytoplasm in Demecolcine-treated
cultures (Fig. 10G). Thus, these results implicate microtubules
in the nuclear transport of PTHrP in trophoblast cells.
Recently, we reported that PTHrP increases the expression
and nuclear staining of AP-2g protein (El-Hashash et al.,
2005), an essential transcription factor for the development of
extra-embryonic tissues (Auman et al., 2002). Cytoplasmic AP-
2g protein, like PTHrP, was associated with filamentous
structures in preliminary experiments. To explore whether the
AP-2g-associated filaments were microtubules, double staining
of trophoblast cells was performed using antibodies for AP-2g
and h-tubulin (Figs. 11A–C). Both AP-2g and microtubules
were associated in trophoblast cells with giant nuclei (Figs.
11A–C), and the two secondary antibodies did not cross react
(Fig. 11H). The association of AP-2g protein with h-tubulin-
stained microtubules was clearly evident when green and red
channel images were merged (Fig. 11C). Disrupting micro-
tubules with Demecolcine rendered AP-2g-nuclear staining
undetectable (Figs. 11D, E). AP-2g staining was restricted to
the cytoplasm (Fig. 11E), suggesting a role for microtubules in
endogenous AP-2g nuclear import. Vehicle control incubations
with DMSO showed no changes in h-tubulin-stained micro-
tubules or AP-2g staining (data not shown).
To examine whether neutralising PTHrP action could mimic
the effect of inhibiting microtubules on AP-2g-nuclear
localisation, the nuclear staining of AP-2g was compared
between PTHrP-treated trophoblasts and those treated with
PTHrP-neutralising antibody (Figs. 11F, G). AP-2g nuclear
staining was undetectable in cells treated with PTHrP-
neutralising antibody (Fig. 11G), but was intense in PTHrP-
treated cells (Fig. 11F). AP-2g was very weakly expressed inthe cell cytoplasm after blocking PTHrP (Fig. 11G) compared
to PTHrP-treated cells (Fig. 11F), supporting the suggestion
that PTHrP plays a role in AP-2g nuclear import and protein
synthesis.
Discussion
Changes in cell polarity, cytoskeleton organisation, and cell
morphology and motility are known to be fundamental
elements of many different developmental events, including
TGC differentiation. The proliferative, cohesive and nonmotile
TS cells are suggested to undergo an epithelial–mesenchymal
transition (EMT) to differentiate into highly motile intermedi-
ate cells (Parast et al., 2001). This EMT is characterised by a
destabilised cell–cell contact, and increasing actin cytoskeleton
organisation, cell motility and protrusive activity. Intermediate
trophoblast cells then undergo a reepithelisation to form TGCs,
which have stabilised cell–cell and cell–matrix interactions,
with little or no motility (Parast et al., 2001).
The role of many growth factors and cytokines in murine
and human trophoblast development has been identified.
However, little is known about the intrinsic factor(s) and
environmental cues from the uterus/embryo regulating the
cellular and behavioural changes occurred during TGC
differentiation. For instance, insulin-like growth factor-I
(IGF-I) increases the formation of actin stress fibres and
promotes adhesion of human trophoblast cells in vitro (Kabir-
Salmani et al., 2002). We have shown that PTHrP regulates
cellular changes during TGC differentiation, including actin
stress fibre formation and organisation, expression of E-
cadherin and subcellular localisation of h-catenin. This was
accompanied by changes in the expression and phosphoryla-
tion of several Eph/Ephrins and in RhoGTPases’ levels, key
regulators of the cytoskeleton and adhesion. PTHrP also
showed a microtubule-dependent nuclear translocation during
TGC differentiation.
PTHrP regulation of TGC morphology and phenotype
The stimulatory effect of PTHrP on trophoblast cellular
differentiation was clearly demonstrated by its induction of the
formation and organisation of actin fibres, resulting in a
characteristic flattened and fibroblastic morphology of differ-
entiated TGCs. This was accompanied with the repression of
E-cadherin expression (this paper) and an increase in cell
spreading in serum-free culture (El-Hashash et al., 2005).
Blocking PTHrP action confirmed its action by preventing
these cellular changes. It also resulted in loss of the flattened/
fibroblastic morphology of TGCs and acquisition of rounded
cell shape, and probably reepithelisation.
One possible mechanism that may account for PTHrP
induction of trophoblast differentiation is the reduction of E-
cadherin expression and activity. When rat TGCs become
invasive, E-cadherin is downregulated (Damjanov et al., 1986),
as it is during the differentiation of human syncytotrophoblasts
(MacCalman et al., 1996). PTHrP increased the nuclear
localisation of h-catenin (this paper; Foley et al., 2001) that
Fig. 10. (A) Triple labelling of day 2 trophoblast cells with antibody against PTHrP (green), Texas-Red Phalloidin for F-actin (red), and DAPI (blue). (B–D)
Confocal microscope images of secondary trophoblast cells stained with antibody for endogenous PTHrP (green) (B), or h-tubulin (red) (C). (D) merged Z-stack
image of panels B and C with colocalisation in yellowish green (arrowheads). (E) triple labelling (merged images) for endogenous PTHrP (green), microtubules (red)
and DAPI (blue) showing alignment of PTHrP proteins on the microtubules in the cytoplasm (arrowheads). Note the punctate pattern of localisation of PTHrP in
panel E. (F, G) Effect of inhibiting microtubules using Demecolcine on PTHrP nuclear translocation in day 2 trophoblast cells. (F) Stained with antibody for h-
tubulin. (G) Merged images of endogenous PTHrP stained with antibody for PTHrP, (F) and DAPI labelling. Note high cytoplasmic, but not nuclear, staining for
PTHrP (arrowhead). (H) Control staining for PTHrP and h-tubulin after replacing the secondary antibody of PTHrP (anti-rabbit IgG) with that for h-tubulin (anti-
mouse IgG) double labelled with DAPI. Scale bar: 10 Am.
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transcription through active LEF-1/h-catenin complex (Jamora
et al., 2003). The lack of E-cadherin in E-cad/ embryonic
stem (ES) cells results in an elevated nuclear pool of h-catenin
(Orsulic et al., 1999). PTHrP also repressed cdc42 expression,
a positive regulator of E-cadherin activity (Nagafuchi et al.,
1994). Inhibition of cdc42 perturbs cell–cell adhesion in
MDCK cells (Kuroda et al., 1997). Interestingly, PTHrP
repression of E-cadherin may accelerate trophoblast cell entryinto S-phase and cell proliferation. PTHrP stimulates secondary
trophoblast proliferation and DNA synthesis (El-Hashash et al.,
2005); while E-cadherin overexpression results in increasing
the level of cyclin-dependent kinase inhibitors, reduction of
cyclin D1 and dephosphorylation of retinoblastoma (Rb)
protein in different cell types (St Croix et al., 1998). Exposure
of E-cadherin transfected cells to E-cadherin-neutralising
antibodies stimulates cell proliferation and prevents cell
adhesions (St Croix et al., 1998). In combination, these
Fig. 11. (A–C) Immunolocalisation of AP-2g (A, green) and h-tubulin (B, red). (C) Merged images of (A, B and DAPI), with co-staining in yellowish green. Note
association of endogenous AP-2g with microtubules (C, arrowheads). (D, E) Effect of inhibiting microtubules using Demecolcine on AP-2g nuclear localisation in
day 2 trophoblast cells. (D) Stained with antibody for h-tubulin. (E) Merged images of AP-2g stained with anti-AP-2g, (D) and DAPI labelling. Note intense
cytoplasmic, but not nuclear, staining of AP-2g (E, arrowheads). (F, G) Effect of neutralising PTHrP action on the nuclear localisation of AP-2g in day 2 trophoblast
cells (images merged with DAPI). (F) Nuclear staining for AP-2g (green, arrow) in PTHrP-treated cells. (G) Undetectable nuclear AP-2g-staining and very weak
cytoplasmic AP-2g expression in cells treated with PTHrP-neutralising antibody. (H) control staining with anti-AP-2g followed by anti-mouse IgG (secondary
antibody for anti-h-tubulin), double labelled with DAPI. Scale bar: 10 Am.
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based cell–cell contact through the E-cadherin-regulators, h-
catenin and cdc42. The elevation of E-cadherin mRNA and
protein after blocking PTHrP action supports this hypothesis,
but further investigation is needed to confirm it.
Furthermore, the reduction of Rac1 expression may induce
the repression of E-cadherin and the reorganisation of actin
stress fibres in proliferating trophoblast cells near the explant.Blocking endogenous Rac downregulates E-cadherin expres-
sion in epithelial and MDCK cells (Braga et al., 1997;
Kuroda et al., 1997), while active Rac inactivates Rho and
suppresses actin stress fibre organisation in different cell
types (Sander et al., 1999; O’Conner and Mercurio, 2001).
The increase of Rac1 expression in peripheral, differentiated
TGCs may induce cyclin D1 expression that is necessary for
DNA endoreduplication. Overproduction of activated Rac
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et al., 2001). Interestingly, we reported PTHrP stimulation of
cyclin D1 expression and DNA synthesis during secondary
TGC differentiation in vitro (El-Hashash et al., 2005).
Overexpression of cdc42 in quiescent fibroblasts promotes
entry into G1 and progression to S phase (Qiu et al., 1997),
but cdc42 activity decreases with TGC differentiation (Parast
et al., 2001). The repression of cdc42 expression on later
days of culture, particularly after addition of PTHrP, may
cease DNA endoreduplication in late, terminally differentiated
TGCs.
PTHrP regulates cell cytoskeleton-regulating molecules:
Eph/Ephrin and RhoGTPases
Our results suggested that PTHrP acts through EphB2/RhoA
signalling to enhance actin synthesis and cytoskeletal organi-
sation during TGC differentiation in vitro. PTHrP increased the
expression and phosphorylation of EphB2 and expression of
RhoA, and enhanced actin stress fibre formation on later days
of culture.
The expression of RhoGTPases, RhoA, cdc42, and Rac1,
apparently regulated by PTHrP occurs in parallel with changes
in EphB2/EphrinB1 synthesis and phosphorylation in second-
ary trophoblasts. This is consistent with the well-documented
involvement of RhoGTPases, a downstream target for Eph/
Ephrin, in the regulation of actin cytoskeleton assembly in
response to growth factors and cell adhesion receptors (Nobes
and Hall, 1995). Eph receptors negatively regulate the MAPK/
ERK pathway which results in reduction of mitogenic
signalling and induction of cytoskeletal reorganisation in
cultured neurons (Elowe et al., 2001). In neuronal and
melanoma cells, both EphA/EphrinA and EphB/EphrinB
kinases activate Rho, which stabilises actin filaments (Luo,
2000; Dickson, 2001), causing actin cytoskeleton reorganisa-
tion (Meima et al., 1997a,b; Jurney et al., 2002) and changes in
cell morphology and adhesion (Wahl et al., 2000; Lawrenson et
al., 2002). Active EphB2 kinase activates Ras-GAP leading to
reduced expression levels of active Ras-GTP which acts
specifically to inhibit Rho-GTP in different cells (Elowe et
al., 2001; Tong et al., 2003). Notably, consistent with PTHrP
stimulation of EphB2/EphrinB1, and effects of EphB2/
EphrinB1 on cell mitogenesis and the cytoskeleton, we
reported a reduction of cell proliferation (El-Hashash et al.,
2005) and enhancement of actin cytoskeleton formation and
organisation (above) in PTHrP-treated trophoblast cells of later
culture days.
Signalling through more than one pathway could account
for the pleiotropic effects of PTHrP described in different
cell types. PTHrP interacts with its receptor to activate
PKC-, PKA-Ras/MAPK or both in osteoblasts, fibroblasts
and human term placenta (Abou-Samra et al., 1992; Miao et
al., 2001; Fortino et al., 2002; Laramee et al., 2002). Since
the involvement of Eph/Ephrin kinases and RhoGTPases in
PTHrP signalling has not been reported in any other cell
type, parallel studies cannot be cited to support our proposal
that PTHrP can signal through EphB/Rho. Further work willbe needed to confirm this novel signalling pathway for
PTHrP in trophoblast cells. However, the implication of
EphB tyrosine kinase and RhoA in the control of trophoblast
cytoskeleton and development is likely for several reasons.
EphrinB2, EphA2 and EphrinA1 have recently been detected
in human placenta and suggested to play a role in
trophoblast development (Goldman-Wohl et al., 2004).
Transfection of the neuronal cell line (NG108) with EphB2
cDNA leads to inhibition of Ras-MAPK signalling and
changes in the actin cytoskeleton, which are impaired after
the expression of a constitutively active variant of Ras
(Elowe et al., 2001). Indeed we found that PTHrP inhibits
phosphorylation of Ras and PKC in day 3 cultures, in
parallel to reorganisation of the trophoblast actin cytoskele-
ton (El-Hashash and Kimber, unpublished). Also, treatment
of fibroblasts with a Rho inhibitor causes disappearance of
actin stress fibres (Chardin et al., 1989), and blocks Eph
kinase stimulation of actin reorganisation (Wahl et al., 2000)
in different cell types.
PTHrP signals through activation of phosphatidyl inositol 3-
kinase (PI3-kinase) in the human osteoblast-derived osteosar-
coma cells (Carpio et al., 2001), and elevates nuclear h-catenin
(this work; Foley et al., 2001). These findings suggest two
mechanisms for PTHrP action on EphB/EphrinB in trophoblast
cells. It is possible that PI3-kinase and Src are involved in
PTHrP activation of EphB2/EphrinB in day 3 secondary
trophoblast cells. For instance, PTHrP can activate G protein
hg subunit leading to activation of PI3-kinase and Src protein
kinase in myeloid-derived cells and osteoblast cell lines
(Stephens et al., 1994; Clapham and Neer, 1997; Carpio et
al., 2001). In turn, Src is expressed in rat trophoblast and Rcho-
1 cells (Kamei et al., 1997), and can phosphorylate EphrinB
and in turn EphB (Kalo and Pasquale, 1999).
A second possible mechanism for PTHrP action on EphB2/
EphrinB kinases in trophoblasts may involve h-catenin-
induced gene transcription. Upon association with LEF-1, h-
catenin enters the nucleus (Behrens et al., 1996; Huber et al.,
1996) and activates Tcf-4 transcription factor, which regulates
the expression of EphB2/EphB3 and EphrinB1 in intestinal
epithelium cells (Batlle et al., 2002). In mammary mesen-
chyme, disruption of PTHrP signalling results in the abolition
of nuclear h-catenin as well as LEF-1 expression, while both
reappear in the nucleus when PTHrP is overexpressed (Foley
et al., 2001).
PTHrP and AP-2c nuclear localisation depends on
microtubule integrity in trophoblast cells
In addition to its well-recognised autocrine/paracrine bio-
logical roles, PTHrP has intracrine actions. PTHrP enters the
nucleus under the direction of the NLS (Henderson et al.,
1995). It shuttles between the cytoplasm and nucleus through
the nuclear pore complex and dependent on microtubule
integrity (Lam et al., 2002). PTHrP colocalises with micro-
tubules, and both PTHrP nuclear accumulation and nucleocy-
toplasmic flux alter after their disruption (Lam et al., 2002).
Similarly in this work, PTHrP was colocalised with micro-
A.H.K. El-Hashash, S.J. Kimber / Developmental Biology 290 (2006) 13–31 29tubules in secondary trophoblast cells, and disrupting them
abolished the nuclear localisation of endogenous PTHrP.
Interestingly, cytoplasmic AP-2g was also associated with
microtubules in trophoblast cells; while their disruption
rendered AP-2g nuclear staining undetectable. This suggests
the importance of microtubules in the nuclear transport of AP-
2g, a finding that has not been reported yet in other cell types.
The precise role of the nuclear translocation of PTHrP
remains to be established, although it is clearly implicated in
promoting cell proliferation (Lam et al., 1997; Massfelder et
al., 1997) and delaying apoptosis (Henderson et al., 1995) in
several cell types. Consistent with these studies, PTHrP
protein appears to have different intracrine actions in
secondary trophoblast cells as they differentiate. Nuclear
entry of PTHrP protein in proliferating trophoblast cells of
early cultures is greater than in markedly differentiated TGCs
of day 3 cultures (El-Hashash et al., 2005). One possibility is
that PTHrP binds to and acts as a nuclear exporter/importer
for nuclear or cytoplasmic mRNAs (Aarts et al., 1999a,b) or
proteins (Fiaschi-Taesch and Stewart, 2003). The latter is
likely in secondary trophoblast cells as PTHrP induces the
expression and nuclear localisation of AP-2g, which we have
suggested to mediate some of PTHrP’s actions on TGC
development in vitro (El-Hashash et al., 2005). Blocking
PTHrP function abolished its effect on AP-2g, including
nuclear localisation, mimicking the effect of microtubule
disruption seen in this study.
In conclusion, PTHrP could regulate a complex network of
events involved in trophoblast cellular differentiation, and our
findings will help to stimulate further work testing the
signalling pathways involved in trophoblast differentiation
and placenta formation.
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